Author:
Nicolini F. E.,Michallet M.
Publisher
Computers, Materials and Continua (Tech Science Press)
Reference85 articles.
1. Allan EK, Holyoake TL, Craig AR, Jorgensen HG (2011) Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells. Leukemia 25: 985–994
2. Baccarani M, Akard L, Kantarjian H, et al (2012) Efficacy and safety analysis of subcutaneous omacetaxine mepesuccinate in patients with chronic myeloid leukemia startified by resistance/intolerance to at least 2 tyrosine kinase inhibitor therapies. Haematologica 97
3. Baccarani M, Cortes J, Pane F, et al (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European Leukemia Net. J Clin Oncol 27: 6041–6051
4. Bacher U, Klyuchnikov E, Zabelina T, et al (2009) The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia: a report from the German Registry covering the period from 1998 to 2004. Ann Hematol 88: 1237–1247
5. Bittencourt H, Funke V, Fogliatto L, et al (2008) Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase. Bone Marrow Transplant 42: 597–600